Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Partially Realized Potential https://t.co/OSKHcRN9vP
Review | Immune checkpoint inhibitors in small cell #LungCancer: a partially realized potential. https://t.co/4GAdMmBFAn
RT @TGOliver2: Nice. Thanks for posting. I would love for the field to figure out whether immunotherapy differences exist among recently de…
Nice. Thanks for posting. I would love for the field to figure out whether immunotherapy differences exist among recently described #sclc subtypes: ASCL1, NEUROD1, YAP1, POU2F3. https://t.co/lTzvCEzfvu
RT @StephenVLiu: Short #SCLC review written by our first year @Georgetown fellow Dr. #SamanthaArmstrong - always impressed (/proud) when fe…
RT @StephenVLiu: Short #SCLC review written by our first year @Georgetown fellow Dr. #SamanthaArmstrong - always impressed (/proud) when fe…
RT @StephenVLiu: Short #SCLC review written by our first year @Georgetown fellow Dr. #SamanthaArmstrong - always impressed (/proud) when fe…
RT @StephenVLiu: Short #SCLC review written by our first year @Georgetown fellow Dr. #SamanthaArmstrong - always impressed (/proud) when fe…
RT @StephenVLiu: Short #SCLC review written by our first year @Georgetown fellow Dr. #SamanthaArmstrong - always impressed (/proud) when fe…
Short #SCLC review written by our first year @Georgetown fellow Dr. #SamanthaArmstrong - always impressed (/proud) when fellows early in training find time between clinical duties and studying to author papers. @LombardiCancer @AdvancesTherapy #LCSM https